Importantly, 5FU-based combination treatment also shows an increase in mitochondrial mass (FOLFOX (5FU + 1 M oxaliplatin) or FOLFIRI (5FU + 5 nM SN38, active metabolite of irinotecan)) that we attribute to 5FU-imposed stress, given that single-agent oxaliplatin or SN38 do not promote the same degree of mitochondrial adaptation (Extended Data Fig
The manufacturer, Eli Lilly Co., has submitted orforglipron to the FDA for approval for use in weight management, with a decision expected in the second quarter of 2026
Because appetite is suppressed, it becomes easy to prioritize easy foods or skip meals altogether
Protective effects of l-carnitine on astheno- and normozoospermic research subjects [PMID: 26081351] Laboratory literature summary: Protective effects of l-carnitine on astheno- and normozoospermic research subjects semen samples during cryopreservation
This medication is not suitable for people with glaucoma, hyperthyroidism, or a history of stroke, substance use disorder, or some types of psychiatric illness